Citrullinemia is a rare genetic condition that affects how the body removes ammonia. It often starts in newborns or early childhood, but some people are diagnosed later. Early signs can include poor feeding, vomiting, sleepiness, and confusion, and doctors may see high ammonia levels in blood tests. Treatment focuses on lowering ammonia with special diets, medicines, and sometimes dialysis or liver transplant, and many people with citrullinemia do well with prompt care. Severe crises can be life-threatening, so quick treatment and lifelong follow-up are important.
Overview
CitrullinemiaSymptoms
Citrullinemia features appear in newborns: poor feeding, vomiting, sleepiness, fast breathing, and seizures from high ammonia. Older children or adults may have headaches, confusion, behavior changes, or coma after high-protein intake or illness. Early signs of citrullinemia warrant urgent care.
Outlook and prognosis
Many people with citrullinemia live well with early diagnosis, careful diet, and quick treatment during illnesses. Outlook varies by type: newborn-onset tends to be more serious, while later-onset can be milder. Regular monitoring helps protect the brain and prevent complications.
Causes and risk factors
Citrullinemia stems from inherited gene changes (usually autosomal recessive), sometimes recognized in newborns. Risk is higher with family history or parents who are related. Common triggers of citrullinemia episodes include high-protein intake, fasting, infection, surgery, medicines, dehydration, and physical stress.
Genetic influences
Genetics are central to citrullinemia. It’s an inherited condition caused by changes in the ASS1 (type I) or ASL/other genes (type II), passed in an autosomal recessive pattern. Variants influence severity, age at onset, and response to treatment.
Diagnosis
Doctors suspect Citrullinemia from clinical features or newborn screening, then check blood ammonia and plasma amino acids for high citrulline. Urine tests may support it. Genetic tests confirm the diagnosis; this is the genetic diagnosis of Citrullinemia.
Treatment and drugs
Treatment for citrullinemia focuses on lowering ammonia and supporting the liver and brain. Care often includes a low-protein diet with special medical formulas, ammonia‑scavenging medicines, and prompt treatment during illness; some receive liver transplantation. Regular metabolic specialist follow‑up helps adjust plans.
Symptoms
Citrullinemia can cause sudden or ongoing problems when ammonia builds up in the blood. Clinicians call this hyperammonemia, which means ammonia builds up in the blood faster than the body can clear it. It can start in the first days of life or appear later in childhood or adulthood, depending on the type. Parents often look for early features of Citrullinemia like poor feeding, sleepiness, or vomiting, while adults may notice confusion or behavior changes during episodes.
Newborns may refuse feeds, spit up repeatedly, or lose interest in eating. This often appears within the first days after birth as ammonia rises. In Citrullinemia, feeding trouble can worsen quickly.
Babies can be unusually drowsy or hard to wake; older children and adults may feel extreme fatigue. This reflects the brain being affected by high ammonia. Low energy can come and go between episodes.
Babies may cry inconsolably or seem unusually restless. Children may be cranky or have trouble settling. These changes can track with ammonia swings in Citrullinemia.
You might notice quick, deep breaths as the body tries to rebalance. This can happen during an ammonia spike. Breathing may look normal again once levels fall.
How people usually first notice Citrullinemia?
Families often notice the first signs of citrullinemia in the newborn period, when a baby who seemed well develops poor feeding, vomiting, unusual sleepiness, or rapid breathing within the first few days of life; seizures or a floppy (low‑tone) feel can also appear as ammonia builds up. Doctors may pick it up through newborn screening or urgent blood tests showing very high ammonia levels, prompting evaluation for a urea cycle disorder like citrullinemia. In milder or late‑onset forms, the first signs of citrullinemia can appear later in childhood or adulthood as episodes of confusion, headache, nausea, or behavior changes during illness, high‑protein intake, or fasting.
Types of Citrullinemia
Citrullinemia has a few well-recognized clinical variants that differ in age at onset, severity, and which organs are most affected. These variants relate to changes in enzymes of the urea cycle, which help clear ammonia from the blood. Symptoms don’t always look the same for everyone. Knowing the main variants can help you and your care team talk about types of Citrullinemia and what to expect day to day.
Type I (ASS1)
Classically appears in newborns with high ammonia levels, poor feeding, vomiting, and sleepiness. Some develop later-onset episodes in childhood or adulthood triggered by illness or high-protein loads. Between crises, many feel well but remain at risk for sudden decompensation.
Type II (SLC25A13)
More often presents in teens or adults with confusion, behavior changes, or coma during hyperammonemia. Some infants, especially in East Asian populations, show a liver-based form with jaundice and growth issues. Food preferences for high-fat and low-protein foods can be a clue in older individuals.
Citrin deficiency neonatal form
In early infancy, some have prolonged jaundice, poor weight gain, and liver dysfunction due to citrin deficiency. Neurologic ammonia crises are less typical at this stage but can occur later. Care often focuses on specialized nutrition and close liver monitoring.
Late-onset citrullinemia
Describes episodes beginning after infancy with confusion, headache, or irritability during metabolic stress. Doctors sometimes classify symptoms as acute crises versus between-episode stability. Triggers often include infection, fasting, childbirth, or excess protein.
Milder/variant presentations
Some people have partial enzyme activity and milder, intermittent symptoms. Even within the same type, intensity can range from mild to severe. Tracking personal triggers helps guide prevention and treatment.
What genetics can tell you about symptoms
Some people with specific ASS1 gene changes (type I) develop newborn jaundice, vomiting, extreme sleepiness, or seizures because ammonia builds up when the urea cycle stalls. Others with SLC25A13 changes (type II) may have episodes later, with confusion, irritability, poor appetite, and liver problems.
Causes and risk factors
Most cases of Citrullinemia come from changes in the ASS1 or SLC25A13 genes that affect the urea cycle. These changes are usually inherited from both parents, but a new change can sometimes arise. Some risks are written in our DNA, passed down through families. Illness or fasting can raise ammonia, and high protein diets or certain medicines can also trigger episodes. Knowing your family history and early symptoms of Citrullinemia can help you seek testing and avoid triggers.
Environmental and biological risk factors
Living with Citrullinemia often means watching for body states or outside exposures that can tip ammonia balance and trigger symptoms in everyday life. Genes provide a baseline, but daily surroundings add new layers. Infections, surgeries, and certain medicines can set off early symptoms of Citrullinemia, especially when the body is under stress. Below are environmental and biological factors that can raise the chance of an episode.
Illness increases protein breakdown and raises ammonia levels. People with Citrullinemia are more likely to have an episode during febrile infections. The added metabolic demand can unmask or worsen symptoms.
Physical stress hormones drive catabolism, increasing ammonia production. Anesthesia-related fasting and tissue injury add to the load.
Valproate, some chemotherapy medicines, and high-dose steroids can raise ammonia or impair its handling. In Citrullinemia, these drugs can quickly precipitate symptoms.
Rapid protein delivery through tube feeds or IV nutrition increases nitrogen presented to the urea pathway. This is especially risky during recovery from illness or surgery.
Genetic risk factors
Genes that help clear ammonia from the blood sit at the center of citrullinemia. Changes in these genes can reduce the urea cycle’s efficiency and allow ammonia to build up, sometimes quickly. Some risk factors are inherited through our genes. Understanding which gene is involved helps explain early symptoms of citrullinemia and why they differ from person to person.
ASS1 gene changes: Variants in the ASS1 gene cause citrullinemia type I by lowering a key urea-cycle enzyme’s activity. Both copies of the gene usually need to carry harmful changes for symptoms to develop. This form can appear in the newborn period or later in life.
SLC25A13 (citrin): Changes in the SLC25A13 gene lead to citrin deficiency, known as citrullinemia type II. It can show in infants as liver-related issues or in adults with high ammonia through a different pathway than type I. Both copies must be altered for the condition to develop.
Autosomal recessive pattern: Citrullinemia occurs when someone inherits two nonworking copies of the relevant gene, one from each parent. Carriers with a single change typically have no symptoms but can pass it on. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of an affected child.
Family history factors: Having an affected child or sibling increases the chance that future children could also have citrullinemia. Parents who are related by blood have a higher chance of sharing the same rare gene change.
Ancestry patterns: Some communities have higher carrier rates because of founder variants passed down over generations. Citrin deficiency is more frequent in East Asian populations.
Variant-specific severity: Different changes within ASS1 or SLC25A13 can leave behind varying amounts of function. This helps explain why age of onset and severity vary, even within the same family. The gene can act a bit like a dimmer switch for the urea cycle.
Lifestyle risk factors
Citrullinemia is an inherited urea-cycle disorder; lifestyle habits do not cause it, but they can influence day-to-day ammonia levels and risk of metabolic decompensation. Understanding lifestyle risk factors for Citrullinemia can help reduce emergency episodes and support safer activity, nutrition, and hydration choices. Work closely with your metabolic team to personalize any changes.
Excess dietary protein increases ammonia production the body cannot clear efficiently. Following a protein-controlled plan tailored by your metabolic team lowers the risk of hyperammonemia.
Gaps without calories push the body to break down muscle, releasing ammonia. Regular meals and snacks with adequate carbohydrates help prevent catabolic spikes.
High-intensity or prolonged workouts can trigger catabolism and raise ammonia. Favor moderate, well-fueled activity with rest and monitor for symptoms like headache, confusion, or vomiting.
Low fluid intake can reduce renal clearance and concentrate ammonia. Steady hydration, especially during heat or activity, supports safer ammonia handling.
Risk prevention
Living with citrullinemia means focusing on preventing ammonia from building up, because that’s what causes most complications day to day. You can’t prevent the genetic condition itself, but you can lower the chance of sudden “metabolic crises” with steady routines and quick action when you’re sick. Prevention works best when combined with regular check-ups. Care plans usually blend food strategies, medicines, and emergency steps your team personalizes for you or your child.
Make sure your baby’s state or regional newborn screen is checked and followed up promptly. Early treatment lowers the chance of high ammonia and hospital stays.
Learn the early symptoms of citrullinemia such as poor feeding, vomiting, unusual sleepiness, or confusion. If these appear, seek urgent care for an ammonia check.
Follow a measured, lower-protein meal plan set by your metabolic team. Special medical formulas and essential amino acid mixes can protect growth while limiting ammonia.
Eat regular meals and snacks, and give overnight feeds for infants if advised. Keep fast-acting carbs on hand for illness or delays in meals to prevent breakdown of body protein.
Transmission
Citrullinemia is not contagious; you can’t catch it through contact, coughing, or everyday sharing. The genetic transmission of citrullinemia is autosomal recessive, meaning a child needs to inherit two nonworking copies of the gene—one from each parent—to develop the condition, while carriers usually have no symptoms. If both parents are carriers, each pregnancy has a 25% chance of a child with citrullinemia, a 50% chance of a child who is a carrier, and a 25% chance of neither. Rarely, citrullinemia can occur because of a new genetic change (a de novo mutation), with no prior family history.
When to test your genes
Citrullinemia runs in families, so test genes before pregnancy, during prenatal planning, or if a newborn shows unexplained lethargy, vomiting, or high ammonia. Adults should consider testing with a family history, suggestive symptoms after high‑protein meals, or abnormal liver/ammonia labs. Results can guide diet, medications, emergency plans, and carrier or prenatal options.
Diagnosis
Citrullinemia is usually picked up when a baby, child, or adult has symptoms of high ammonia, like sleepiness, vomiting, confusion, or trouble feeding, and tests point to a urea-cycle problem. Doctors confirm it with specific blood and urine tests and, often, genetic testing to find the underlying change in the gene. Early and accurate diagnosis can help you plan ahead with confidence. In newborns, screening programs can flag high citrulline levels before symptoms appear, which helps start treatment quickly.
A small blood spot is checked for raised citrulline levels using tandem mass spectrometry. Abnormal results prompt repeat testing and confirmatory labs.
Doctors ask about feeding problems, vomiting, sleepiness, confusion, or behavior or mood changes. A focused exam looks for signs of dehydration, liver strain, or neurologic changes.
A rapid blood test checks for high ammonia, which can build up when the urea cycle is not working. Levels that are high for age strongly support a urea-cycle disorder and need urgent attention.
A detailed amino acid panel looks for high citrulline with low arginine. This pattern helps distinguish Citrullinemia from other urea-cycle disorders.
Stages of Citrullinemia
Citrullinemia does not have defined progression stages. The course varies by type and age; some people have sudden episodes of high ammonia with early symptoms of citrullinemia like vomiting, extreme sleepiness, or confusion, while others are identified through newborn screening without a steady, stepwise decline. Different tests may be suggested to help confirm what’s going on, such as newborn screening results, blood ammonia and amino acid levels, and genetic testing. Ongoing care often includes repeat ammonia checks, nutrition and liver monitoring, and watching development over time to catch changes early.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Citrullinemia, the outlook depends on the type, how early it’s found, and how quickly treatment starts during high-risk times like infancy, illness, or surgery. Early care can make a real difference, especially for newborns with the classic (type 1) form: rapid treatment to clear ammonia, strict sick-day plans, and a carefully managed low-protein diet with prescribed supplements can prevent brain injury and support development. People diagnosed later or more mildly may have fewer crises but still need plans to avoid ammonia spikes; skipping meals, dehydration, intense exertion, or infections can all trigger symptoms.
The outlook is not the same for everyone, but with consistent management many living with Citrullinemia attend school or work, exercise within safe limits, and plan travel around meal timing and medications. Early symptoms of Citrullinemia, like vomiting, extreme sleepiness, headache, or confusion during a viral illness, should prompt urgent care, because fast treatment of high ammonia greatly lowers the risk of long-term problems. Some will experience learning or attention challenges after severe episodes; therapies and school supports can help. Adults with type 2 may have long stretches without symptoms, then sudden episodes tied to stress, high-protein intake, or alcohol; avoiding triggers and having rescue plans are key.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Mortality risk is highest during untreated hyperammonemia in infancy or during severe adult crises; with modern newborn screening (where available), emergency protocols, ammonia-lowering medicines, and in some cases liver transplant, survival has improved substantially. Transplant can stabilize ammonia control and reduce hospitalizations, though it brings lifelong anti-rejection medications and follow-up. Knowing what to expect can ease some of the worry. Talk with your doctor about what your personal outlook might look like, including how your specific type, previous ammonia levels, and daily routine influence risk and which steps—diet, medications, sick-day plans, or transplant evaluation—fit your goals.
Long-term effects
Many living with citrullinemia look ahead with questions about brain health, growth, and day-to-day energy. Early symptoms of citrullinemia may be severe in infancy or appear later and come and go, and this pattern often shapes the long-term picture. Long-term effects vary widely, and they depend on age at first episode, how high ammonia levels rose, and the specific type. Some people have few lasting issues, while others live with learning, motor, or liver-related challenges.
Learning and speech delays may persist into school years. Many with citrullinemia benefit from tailored education plans.
Attention, memory, and processing speed can be affected over time. Lasting changes are more likely after severe ammonia spikes in citrullinemia.
Some develop seizures or epilepsy after earlier hyperammonemia. Seizures in citrullinemia can range from brief staring episodes to convulsions.
Low muscle tone, clumsiness, or slower motor milestones may continue. Fine motor tasks and balance can remain challenging in citrullinemia.
How is it to live with Citrullinemia?
Living with citrullinemia often means planning your days around prevention: regular meals, a carefully managed low-protein diet, prescribed supplements like arginine, and quick action at the first hint of illness or confusion to avoid an ammonia spike. Many find life feels stable when routines are in place, but infections, missed meals, or intense exercise can tip the balance, so having an emergency plan and medications on hand matters. Families and friends typically become skilled partners—helping read food labels, noticing early symptoms like irritability or sleepiness, and supporting clinic visits and blood tests. With education, a trusted care team, and clear backup plans, people can go to school, work, and travel, while those around them gain confidence in how to help during stressful moments.
Treatment and drugs
Citrullinemia treatment focuses on keeping ammonia levels safe and preventing sudden spikes that can harm the brain. Care usually includes a low-protein diet designed by a metabolic dietitian, special medical formulas, and medicines that help the body remove extra nitrogen; medicines that ease symptoms are called ammonia-scavenging drugs. During a crisis or when ammonia is high, hospital care with IV medicines, glucose, and sometimes dialysis may be needed, and some children or adults may be candidates for liver transplant to provide the missing enzyme. Treatment plans often combine several approaches, and they’re tailored by a metabolic specialist based on age, lab results, and how often ammonia rises. Keep track of how you feel, and share this with your care team.
Non-drug treatment
Citrullinemia can affect daily eating, energy, and how well the body clears ammonia, which can build up and harm the brain. Non-drug treatments often lay the foundation for day-to-day stability and crisis prevention. Plans are individualized, but most focus on nutrition, preventing long fasts, and having an emergency strategy for illness.
A carefully limited-protein meal plan helps lower ammonia production while keeping growth and strength on track. This can also reduce early symptoms of citrullinemia such as irritability, vomiting, or unusual sleepiness.
Special low-nitrogen formulas provide essential amino acids and nutrients without adding extra protein burden. A metabolic dietitian adjusts the type and amount as needs change with age and activity.
Regular meals and snacks help prevent long gaps that trigger the body to break down its own protein. Overnight feeds may be used in infants or those at higher risk of ammonia spikes.
During infections or poor appetite, temporary protein reduction and extra carbohydrates can prevent dangerous ammonia rises. Families keep an emergency letter and instructions from the metabolic team for quick care.
Your genes may have an impact on how drugs work for you
Medicines for citrullinemia—like nitrogen-scavenging agents and arginine—can work differently depending on gene changes that affect enzyme activity and how the body processes these drugs. Genetic testing helps tailor doses, monitor ammonia more closely, and choose alternatives when side effects emerge.
Pharmacological treatments
Medicines for Citrullinemia aim to keep ammonia at safe levels so thinking, energy, and daily routines stay on track. Early symptoms of Citrullinemia like nausea, confusion, or irritability can improve faster when treatment starts quickly. Not everyone responds to the same medication in the same way. Your team may adjust medicines during illness, growth spurts, or life changes such as pregnancy.
This medicine binds extra nitrogen so your body can pass it out in urine. Dosing may be increased or lowered gradually to keep ammonia stable and limit side effects. Taste or stomach upset can occur, so taking it with food may help.
A liquid form that works like phenylbutyrate but is often easier to take and gentler on the stomach. It’s commonly used for long-term control of Citrullinemia to prevent ammonia spikes. Regular blood tests help fine‑tune the dose.
An older nitrogen-scavenging option that helps clear ammonia by a different route. In some cases, medicines are combined for better ammonia control. Extra sodium in this drug may not suit everyone, so monitoring is important.
Used in hospital for sudden high ammonia, it starts working quickly to bring levels down. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). It’s often paired with other emergency steps your team may take.
Genetic influences
Citrullinemia usually stems from changes in genes that affect how the body clears ammonia; most people inherit one altered copy from each parent. Family history is one of the strongest clues to a genetic influence. Type I involves the ASS1 gene and can appear in newborns or later in life; type II involves the SLC25A13 gene (citrin deficiency) and more often starts in adolescents or adults. Parents who carry one changed copy typically feel well, but each pregnancy has a 25% (1 in 4) chance of a child with citrullinemia, a 50% (1 in 2) chance of a carrier, and a 25% (1 in 4) chance of neither. Genetic testing can confirm the specific gene changes, help explain why symptoms vary from person to person, and guide diet and medication choices. Knowing the genetic type can also help doctors anticipate early symptoms of citrullinemia and plan monitoring for times of stress, illness, or high protein intake that can trigger spikes in ammonia.
Is Citrullinemia genetic?
Genetics are central to citrullinemia. It’s an inherited condition caused by changes in the ASS1 (type I) or ASL/other genes (type II), passed in an autosomal recessive pattern. Variants influence severity, age at onset, and response to treatment.
Pharmacogenetics—how genetics influence drug effects
How treatment is tailored often depends on the exact genetic cause. In Citrullinemia, knowing whether it’s type I or type II (citrin deficiency) helps your team decide on the best balance of diet, amino acid supplements (such as arginine or citrulline), and ammonia‑scavenging medicines. Alongside medical history and lab results, genetic testing can clarify which pathway is blocked and how aggressively to use these therapies. Your genes can also affect how your body handles some medicines and how much benefit you get from a given dose, so drug choice and dosing are usually individualized and adjusted over time. People with some remaining enzyme activity may need lower doses to keep ammonia in a safe range, while those with more severe forms often require higher doses, emergency treatments, or consideration of liver transplant. Pharmacogenetic testing in Citrullinemia doesn’t replace regular blood monitoring; it helps guide care so treatments are safer and more effective for you.
Interactions with other conditions
Illnesses that put the body under stress can trigger or worsen ammonia build‑up, so infections, high fevers, surgery, or even a hard workout may set off a hyperammonemia episode in people with Citrullinemia. Liver problems (including fatty liver) and kidney issues can make it harder to clear waste, while gastrointestinal bleeding or a very high‑protein diet increases the nitrogen load the urea cycle must handle. Certain medicines interact in important ways: valproate (used for seizures or mood), high‑dose steroids, and some chemotherapy drugs can raise ammonia; total parenteral nutrition and crash dieting can do the same by ramping up protein breakdown. In the adult form linked to citrin deficiency, Citrullinemia may occur alongside fatty liver, pancreatitis, or diabetes, and episodes can be brought on by alcohol, infections, or pregnancy and the postpartum period. Interactions can look very different from person to person, so coordinated care between metabolic specialists, hepatology, neurology, and obstetrics is often helpful. Ask if any medications for one condition might interfere with treatment for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns who seemed well at birth but, within days, became unusually sleepy, refused feeds, or breathed fast. Families and midwives noticed that these crises could arrive suddenly after a minor illness or a change in feeding. In some communities, generations remembered relatives with unexplained episodes of confusion in childhood or adulthood, sometimes after a high‑protein meal or heavy exercise, hinting at a pattern long before the cause was known.
From early theories to modern research, the story of citrullinemia moved from bedside observations to biochemical clues. In the mid‑20th century, doctors began testing blood and urine in children with sudden neurologic symptoms and found very high ammonia levels. This pointed to a problem in the body’s main pathway for clearing ammonia, later called the urea cycle. As laboratory methods improved, researchers noticed that some of these children had strikingly high levels of an amino acid named citrulline, which became a hallmark of the condition.
Initially understood only through symptoms, later studies mapped citrullinemia to specific enzyme steps in the urea cycle. One form, often presenting in the newborn period, was linked to a shortage of the enzyme that joins citrulline to another amino acid; this helped explain why early symptoms of citrullinemia can appear within the first week of life. Another form, described in older children and adults, was tied to a transporter in the liver cell’s energy centers. These discoveries clarified why age at onset and triggers vary, and why some people experience liver problems, headaches, or behavior changes before anyone suspects high ammonia.
In recent decades, knowledge has built on a long tradition of observation. Many regions added citrullinemia to newborn screening, allowing doctors to spot elevated citrulline before symptoms start. Genetics advanced the field further by identifying changes in the genes behind these enzyme and transporter problems, which also confirmed that citrullinemia can run in families even when previous generations went undiagnosed. With this understanding, care strategies shifted: instead of reacting to crises alone, teams could prevent them with tailored diets, emergency plans for illness, and, in some cases, liver transplantation.
Despite evolving definitions, the core lesson from the history of citrullinemia is consistent: brief, unexplained episodes—whether in a newborn or an adult—can signal a hidden problem with clearing ammonia. Looking back helps explain why early recognition and prompt treatment make such a difference today, and why family history, however fragmentary, still matters in guiding testing and care.